Pericardial effusion after pediatric hematopoietic cell transplant

Pediatric Transplantation

Volumn 17, Issue 3, 2013, Pages 294-299

  Aldoss, Osamah ^a   Gruenstein, Daniel H ^a   Bass, John L ^a   Steinberger, Julia ^a   Zhang, Yan ^b   Defor, Todd E ^b   Tolar, Jakub ^a   Verneris, Michael R ^a   Orchard, Paul J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

delayed engraftment; hematopoietic cell transplant; myeloablative conditioning; pericardial effusion

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; ENGRAFTMENT; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; NEUTROPHIL; OVERALL SURVIVAL; PEDIATRIC SURGERY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SURGICAL MORTALITY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; NEUTROPHILS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84876697672     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12062     Document Type: Article

References (14)

1. Cairo MS, Heslop H,. Pediatric blood and marrow transplantation: State of the science. Bone Marrow Transplant 2008: 41: 97.
2. Veys PA, Mcavinchey R, Rothman MT, Mair GH, Newland AC,. Pericardial effusion following conditioning for bone marrow transplantation in acute leukaemia. Bone Marrow Transplant 1987: 2: 213-216.
3. Murdych T, Weisdorf DJ,. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 2001: 28: 283-287.
4. Rhodes M, Lautz T, Kavanaugh-McHugh A, et al. Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients. Bone Marrow Transplant 2005: 36: 139-144.
5. Neier M, Jin Z, Kleinman C, et al. Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac disease. Bone Marrow Transplant 2011: 46: 529-538.
6. Angelucci E, Mariotti E, Lucarelli G, et al. Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia. Lancet 1992: 339: 287-289.
7. Lin DY,. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997: 16: 901-910.
8. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999: 94: 496-509.
9. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958: 53: 457-481.
10. Cox DR,. Regression models and life tables. J R Stat Soc Series B 1972: 34: 187-220.
11. Dean RM, Fry T, Mackall C, et al. Association of serum interleukin-7 levels with the development of acute graft-versus-host disease. J Clin Oncol 2008: 26: 5735-5741.
12. Nürnberger W, Michelmann I, Burdach S, Göbel U,. Endothelial dysfunction after bone marrow transplantation: Increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol 1998: 76: 61-65.
13. Schots R, Kaufman L, Van Riet I, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003: 17: 1150-1156.
14. Castagna L, Furst S, El Cheikh J, Faucher C, Blaise D,. Parvovirus B19 as an etiological agent of acute pleuro-pericarditis. Bone Marrow Transplant 2011: 46: 317-318.